Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
209 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03123055 | A Study of B-701 in Combination With Pembrolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma(FIERCE-22) | terminated | Phase 1 / Phase 2 | 28 | Rainier TherapeuticsINDUSTRY | 17 | Mar 18, 2020 | clinicaltrials |
| NCT02401542 | Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma(FIERCE-21) | terminated | Phase 1 / Phase 2 | 71 | Rainier TherapeuticsINDUSTRY |
| 9 |
| Mar 9, 2020 |
| clinicaltrials |
| NCT01621217 | Phase I Study of Cetuximab in Combination With 5-fluoruracil, Mitomycin C and Radiotherapy in Patients With Anal Cancer Stage T2 (>4 cm) - T4 N0-3 M0 or Any T N2-3 M0(NOAC8) | completed | Phase 1 | 21 | Lund University HospitalOTHER | 2 | Feb 28, 2020 | clinicaltrials |
| NCT03628079 | A Clinical Safety and Efficacy Study of Mebendazole on GI Cancer or Cancer of Unknown Origin.(RepoMeb) | terminated | Phase 1 / Phase 2 | 11 | Repos PharmaINDUSTRY | 1 | Jan 22, 2020 | clinicaltrials |
| NCT00419250 | A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia | completed | Phase 1 | 52 | CelgeneINDUSTRY | 7 | Nov 8, 2019 | clinicaltrials |
| NCT00900614 | Safety Study of APR-246 in Patients With Refractory Hematologic Cancer or Prostate Cancer | completed | Phase 1 | 36 | Aprea TherapeuticsINDUSTRY | 1 | Jul 31, 2019 | clinicaltrials |
| NCT02686944 | A Study to Evaluate the Safety of Intuvax Administered Intra-tumorally in Patients With Gastrointestinal Stromal Tumors(GIST) | completed | Phase 1 | 6 | MendusINDUSTRY | 1 | Jul 5, 2019 | clinicaltrials |
| NCT01844947 | Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract(VINSOR) | completed | Phase 1 | 22 | Dr Anders UllénOTHER | 2 | Apr 26, 2019 | clinicaltrials |
| NCT01801111 | A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment | completed | Phase 1 / Phase 2 | 138 | Hoffmann-La RocheINDUSTRY | 16 | Nov 2, 2018 | clinicaltrials |
| NCT02134600 | OmegaChild - Omega-3 Supplementation to Children Previously Treated for Cancer(OmegaChild) | completed | Phase 1 | 40 | Per KognerOTHER | 1 | Aug 28, 2018 | clinicaltrials |
| NCT01911325 | Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) Patients | terminated | Phase 1 | 27 | Novartis PharmaceuticalsINDUSTRY | 8 | Aug 14, 2018 | clinicaltrials |
| NCT00706030 | Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 92 | Puma Biotechnology, Inc.INDUSTRY | 11 | Aug 9, 2018 | clinicaltrials |
| NCT01619423 | A Trial of PledOx + FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Metastatic Colorectal Cancer(PLIANT) | completed | Phase 1 / Phase 2 | 186 | Egetis TherapeuticsINDUSTRY | 8 | Jul 6, 2018 | clinicaltrials |
| NCT01934790 | Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases | completed | Phase 1 / Phase 2 | 45 | BayerINDUSTRY | 7 | Mar 26, 2018 | clinicaltrials |
| NCT00963534 | Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma.(LENA-BERIT) | completed | Phase 1 / Phase 2 | 51 | Lund University HospitalOTHER | 4 | Mar 12, 2018 | clinicaltrials |
| NCT01622439 | Valproate as First Line Therapy in Combination With Rituximab and CHOP in Diffuse Large B-cell Lymphoma(VALFRID) | completed | Phase 1 / Phase 2 | 50 | Lund University HospitalOTHER | 1 | Mar 12, 2018 | clinicaltrials |
| NCT03040401 | A Study of HDC/IL-2 Treatment in Chronic Myelomonocytic Leukemia (CMML) | unknown | Phase 1 / Phase 2 | 15 | Vastra Gotaland RegionOTHER_GOV | 1 | Dec 19, 2017 | clinicaltrials |
| NCT00334646 | Cyclophosphamide Drug Interaction Study In Cancer Patients | terminated | Phase 1 | 25 | GlaxoSmithKlineINDUSTRY | 3 | Nov 17, 2017 | clinicaltrials |
| NCT02132624 | CD19-targeting 3rd Generation CAR T Cells for Refractory B Cell Malignancy - a Phase I/IIa Trial. | completed | Phase 1 / Phase 2 | 15 | Uppsala UniversityOTHER | 1 | Oct 30, 2017 | clinicaltrials |
| NCT01974661 | Phase I Safety Study of Dendritic Cell Vaccine to Treat Patients With Hepatocellular Carcinoma | completed | Phase 1 | 18 | MendusINDUSTRY | 1 | Sep 29, 2017 | clinicaltrials |
| NCT01460420 | Sequential Trial on Reduced Intensity Conditioning (RIC) Allogeneic Transplantation(EMN-alloRIC) | completed | Phase 1 / Phase 2 | 49 | European Myeloma Network B.V.NETWORK | 4 | Jul 6, 2017 | clinicaltrials |
| NCT01798108 | Dose Escalation Study of Radium-223 Dichloride in Patients With Advanced Skeletal Metastases | completed | Phase 1 | 31 | BayerINDUSTRY | 2 | May 19, 2017 | clinicaltrials |
| NCT02379741 | ADC-1013 First-in-Human Study | completed | Phase 1 | 24 | Alligator Bioscience ABINDUSTRY | 3 | Mar 27, 2017 | clinicaltrials |
| NCT01817738 | Trial of RNActive®-Derived Prostate Cancer Vaccine in Metastatic Castrate-refractory Prostate Cancer | terminated | Phase 1 / Phase 2 | 197 | CureVacINDUSTRY | 8 | Feb 17, 2017 | clinicaltrials |
| NCT02025231 | Image Guided Reirradiation of High-grade Glioma | terminated | Phase 1 / Phase 2 | 31 | Rigshospitalet, DenmarkOTHER | 2 | Feb 8, 2017 | clinicaltrials |
| NCT00930514 | A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular Lymphoma | completed | Phase 1 | 281 | Hoffmann-La RocheINDUSTRY | 22 | Nov 2, 2016 | clinicaltrials |
| NCT00261365 | Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010) | completed | Phase 1 / Phase 2 | 80 | Bristol-Myers SquibbINDUSTRY | 7 | Sep 29, 2016 | clinicaltrials |
| NCT02723071 | A Study of Ocrelizumab in Participants With Follicular Non-Hodgkin's Lymphoma (NHL) | completed | Phase 1 / Phase 2 | 48 | Hoffmann-La RocheINDUSTRY | 6 | Mar 30, 2016 | clinicaltrials |
| NCT01573247 | Safety Study of AKN-028 in Patients With Acute Myelogenous Leukemia | terminated | Phase 1 / Phase 2 | 25 | Akinion Pharmaceuticals ABINDUSTRY | 4 | Mar 25, 2016 | clinicaltrials |
| NCT00761384 | High Dose, Absorbed Dose Adjusted 90Y-ibritumomab With Peripheral Blood Stem Cells (PBSC) Support in B-cell Lymphoma(HITT) | completed | Phase 1 / Phase 2 | 7 | Lund University HospitalOTHER | 1 | Feb 19, 2016 | clinicaltrials |
| NCT01455259 | Phase I/IIa AdCD40L Immunogene Therapy for Malignant Melanoma and Other Solid Tumors | completed | Phase 1 / Phase 2 | 30 | Uppsala UniversityOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT00900627 | Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II)(THYME) | completed | Phase 1 / Phase 2 | 330 | AstraZenecaINDUSTRY | 14 | Jan 20, 2016 | clinicaltrials |
| NCT00866281 | A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia | terminated | Phase 1 / Phase 2 | 22 | Novartis PharmaceuticalsINDUSTRY | 5 | Dec 22, 2015 | clinicaltrials |
| NCT00594984 | Phase I/II Combination With Irinotecan- Erbitux | completed | Phase 1 / Phase 2 | 38 | Bristol-Myers SquibbINDUSTRY | 7 | Nov 4, 2015 | clinicaltrials |
| NCT01525017 | A Clinical Study to Evaluate Safety and Immunologic Response of COMBIG-DC, in Patients With Metastatic Kidney Cancer | completed | Phase 1 | 12 | MendusINDUSTRY | 1 | Oct 12, 2015 | clinicaltrials |
| NCT00579475 | The Effect of Mifepristone on Uterine Fibroids and Breast Tissue | completed | Phase 1 | 30 | Karolinska InstitutetOTHER | 1 | May 25, 2015 | clinicaltrials |
| NCT01858116 | PET Study of Breast Cancer Patients Using [68Ga]ABY-025 | completed | Phase 1 / Phase 2 | 16 | Biomedical Radiation SciencesOTHER | 1 | Jan 13, 2015 | clinicaltrials |
| NCT01595087 | A Phase I/II Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC) | completed | Phase 1 / Phase 2 | 28 | DexTech Medical ABINDUSTRY | 1 | Nov 14, 2014 | clinicaltrials |
| NCT01182246 | AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 44 | Axcentua Pharmaceuticals ABINDUSTRY | 1 | Apr 23, 2014 | clinicaltrials |
| NCT01725555 | A Study to Assess the Effect of Food on the Bioavailability of the IGF-1R Inhibitor AXL1717 in Patients With Advanced Malignant Tumors | completed | Phase 1 | 13 | Axelar ABINDUSTRY | 1 | Apr 7, 2014 | clinicaltrials |
| NCT00859729 | Dose Finding Study of a DNA Vaccine Delivered With Intradermal Electroporation in Patients With Prostate Cancer | completed | Phase 1 / Phase 2 | 15 | Uppsala UniversityOTHER | 1 | Mar 17, 2014 | clinicaltrials |
| NCT01457209 | Acupuncture to Treat Insulin Resistance in Women With and Without Polycystic Ovary Syndrome(PCOS-AcupIR) | completed | Phase 1 | 42 | Göteborg UniversityOTHER | 1 | Jan 22, 2014 | clinicaltrials |
| NCT01959438 | Sodium Selenite as a Cytotoxic Agent in Advanced Carcinoma(SECAR) | unknown | Phase 1 / Phase 2 | 32 | Karolinska University HospitalOTHER | 1 | Oct 10, 2013 | clinicaltrials |
| NCT01451008 | Compression Anastomosis Using the Compression Anastomotic Ring-locking Procedure (CARP) | completed | Phase 1 | 25 | Region SkaneOTHER | 1 | Jul 8, 2013 | clinicaltrials |
| NCT01216033 | Exploratory Study of Breast Cancer With ABY025(ABY0125) | completed | Phase 1 / Phase 2 | 7 | Biomedical Radiation SciencesOTHER | 1 | Apr 15, 2013 | clinicaltrials |
| NCT00411580 | Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD) | completed | Phase 1 | 58 | Novartis PharmaceuticalsINDUSTRY | 1 | Mar 29, 2013 | clinicaltrials |
| NCT01025206 | A Study of a Human Anti-Intercellular Adhesion Molecule-1 Monoclonal Antibody, in Patients With Multiple Myeloma | completed | Phase 1 | 35 | BioInvent International ABINDUSTRY | 4 | Mar 15, 2013 | clinicaltrials |
| NCT01058616 | Dose-escalation Study of LTX-315 in Patients With a Transdermally Accessible Tumour | completed | Phase 1 | 14 | Lytix Biopharma ASINDUSTRY | 2 | Feb 11, 2013 | clinicaltrials |
| NCT00635193 | Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin) | completed | Phase 1 / Phase 2 | 138 | AbbVie (prior sponsor, Abbott)INDUSTRY | 9 | Jan 18, 2013 | clinicaltrials |
| NCT01466647 | A Study of the IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC) | completed | Phase 1 | 12 | Axelar ABINDUSTRY | 1 | Nov 12, 2012 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials